The committee heard sustained testimony in support of substitute House Bill 2523 (Community Reinvestment Program), which would set long‑term direction for distributing funds to communities most harmed by past drug‑enforcement policies.
Program overview: Staff briefers described an existing program with a $25 million per‑fiscal‑year base; the proposed substitute includes directions to Commerce for updates and reporting, a requirement for community input, and an intent language to fund the program at $100 million annually (subject to appropriation). The bill also tasks the Washington State Institute for Public Policy with a study of program outcomes.
Witness testimony: Dozens of organizations and small business recipients described CRP outcomes: employment training, small business grants, behavioral‑health investments and violence prevention programs. Testifiers included the Washington Cannabis Alliance, Washington Workforce Association, small‑business recipients (e.g., food and service businesses), and coalition groups representing community‑based organizations. Many witnesses said CRP funds leverage federal and other resources and urged continuing and predictable funding.
Why it matters: Witnesses cited performance metrics — jobs placed, businesses sustained, and behavioral‑health supports — and argued stable funding enables partner organizations to plan staffing and preserve outcomes. The testimony argued that stable CRP funding yields long‑term fiscal and social returns, including reduced future public costs.
Next step: The committee moved the bill forward for executive consideration. Members asked for clarifications on reporting cadence, dashboarding, and the study budget and timeline.